AbbVie Inc (NYSE:ABBV)

60.50
Delayed Data
As of Feb 27
 -0.02 / -0.03%
Today’s Change
45.50
Today|||52-Week Range
70.76
-7.55%
Year-to-Date
Billionaire George Soros Just Dumped These 3 Dividend Stocks
10:56am / MotleyFool.com
Why Momenta Pharmaceuticals, Inc. Jumped Higher Today
Feb 19 / MotleyFool.com
Biotech Head-to-Head: Gilead vs. Celgene
Feb 26 / MotleyFool.com
Is Gilead Sciences Inc. Stock Cheap Now?
Feb 18 / MotleyFool.com
Cyberonics, Sorin Plan to Merge in Latest Tax Inversion Deal
Feb 26 / TheStreet.com
Waiting for the Momenta to Regain
Feb 17 / MotleyFool.com
Heavy News Day For Several Biotech Stocks
Feb 25 / Benzinga
Surprise! We Still Need Drugmakers to Develop Revolutionary Hepatitis C Drugs
Feb 17 / MotleyFool.com
3 Stocks Boosting The Drugs Industry Higher
Feb 24 / TheStreet.com
Be Careful: These Biotechs Have Run Too Far Too Fast
Feb 16 / MotleyFool.com
Express Scripts Earnings Set the Stage for Growth
Feb 24 / MotleyFool.com
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Feb 16 / MotleyFool.com
UPDATE: Results from AbbVie's Study of VIEKIRA PAK
Feb 23 / Benzinga
The Small-Cap Biotech Stock You Should Be Watching
Feb 15 / MotleyFool.com
Results from AbbVie's Study of VIEKIRA PAKb" (ombitasvir, paritaprevir, ritonavir tabl...
Feb 23 / Benzinga
1 George Soros Quote Every Investor Should Read Right Now
Feb 15 / MotleyFool.com
Valeant Pharmaceuticals Buys Salix Pharmaceuticals in $14.5 Billion Megadeal
Feb 23 / TheStreet.com
Monday interview: Flemming Ornskov, Shire CEO
Feb 15 / FT.com
Why I Favor Big-Cap Growth Stocks
Feb 23 / TheStreet.com
Two's a duopoly, three's awkward for Kirstie, Phil and Zoopla
Feb 12 / FT.com
CNBC's Stock Pops & Drops From February 20
Feb 22 / Benzinga
Shire says $1.6bn windfall from AbbVie is tax-free
Feb 12 / FT.com
There Are Crazy Valuations, and Then There Are the Valuations of These 3 Stocks
Feb 22 / MotleyFool.com
Healthcare: The race to cure rising drug costs
Feb 10 / FT.com
3 Biotech Stocks I'd Love to Stash Away in My Portfolio Forever
Feb 22 / MotleyFool.com
Gilead to cut price of $1,000-a-day pill
Feb 03 / FT.com
Pssst... Pfizer Just Told Investors That This is the Next Big Thing
Feb 21 / MotleyFool.com
Big pharmaceuticals groups faces biosimilars challenge
Feb 02 / FT.com
Will Express Scripts (ESRX) Beat Q4 Earnings Estimates? - Analyst Blog
Feb 20 / Zacks.com
Shire gets go-ahead to market binge-eating medicine
Feb 01 / FT.com
$20 Billion Market: Whatbs the Best Stock to Buy?
Feb 20 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account